E
Emmanuel J. Favaloro
Researcher at Westmead Hospital
Publications - 731
Citations - 22370
Emmanuel J. Favaloro is an academic researcher from Westmead Hospital. The author has contributed to research in topics: Von Willebrand disease & Medicine. The author has an hindex of 60, co-authored 648 publications receiving 18261 citations. Previous affiliations of Emmanuel J. Favaloro include University of Verona & University of Sydney.
Papers
More filters
Journal ArticleDOI
Harmonisation of D-dimer - A call for action
Colin Longstaff,Dorothy M. Adcock,John D. Olson,Ian Jennings,Steve Kitchen,Nicola J. Mutch,Piet Meijer,Emmanuel J. Favaloro,Giuseppe Lippi,Jecko Thachil +9 more
Journal ArticleDOI
Identification of factor inhibitors by diagnostic haemostasis laboratories. A large multi-centre evaluation
Emmanuel J. Favaloro,Roslyn Bonar,Elizabeth J. Duncan,Gail Earl,Joyce Low,Margaret Aboud,Sarah Just,John Sioufi,Alison Street,Katherine Marsden +9 more
TL;DR: Although laboratories are able, in most cases, to identify the presence of true factor inhibitors, there is a large variation in identified inhibitor levels and there are also some significant errors in identification (i.e. false negatives and misidentifications).
Journal ArticleDOI
Evaluation of a von Willebrand factor three test panel and chemiluminescent-based assay system for identification of, and therapy monitoring in, von Willebrand disease.
TL;DR: The chemiluminescent test panel showed good comparability to similar assays performed by alternate methods, and broadly similar data for identification of VWD, provisional VWD type identification, DDAVP and VWD therapy, and HMW VWF sensitivity, although some notable differences were evident.
Journal ArticleDOI
C-reactive protein and venous thromboembolism: causal or casual association?
TL;DR: There is increasing emphasis that CRP might not only be a marker but also an active player in the development of venous thrombosis, and further evidence is needed to establish which event comes first – thromBosis or inflammation.
Journal ArticleDOI
Laboratory testing for suspected COVID-19 vaccine-induced (immune) thrombotic thrombocytopenia.
TL;DR: In this paper, the authors reviewed the laboratory test processes, as utilised to assess suspected VITT, and noted that there are notable similarities and divergences in testing approaches, potentially leading to identification of slightly disparate patient cohorts.